Gaps arising from randomized controlled trials on thrombolysis for proximal deep vein thrombosis of the lower limb.

[1]  Steven D. Abramowitz.  Effective Removal of Chronic Thrombus With the ClotTriever System: Results from the CLOUT Registry , 2021 .

[2]  P. Libby,et al.  Time-Restricted Salutary Effects of Blood Flow Restoration on Venous Thrombosis and Vein Wall Injury in Mouse and Human Subjects. , 2021, Circulation.

[3]  P. Kolh,et al.  European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis. , 2020, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[4]  R. Chopard,et al.  Diagnosis and Treatment of Lower Extremity Venous Thromboembolism: A Review. , 2020, JAMA.

[5]  W. Ageno,et al.  American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. , 2020, Blood advances.

[6]  T. Maldonado,et al.  Management of Inferior Vena Cava Thrombosis with FlowTriever and ClotTriever Systems. , 2020, Journal of vascular surgery. Venous and lymphatic disorders.

[7]  E. Azene,et al.  Correlation between Post-Procedure Residual Thrombus and Clinical Outcome in Deep Vein Thrombosis Patients Receiving Pharmacomechanical Thrombolysis in a Multi-center Randomized Trial. , 2020, Journal of vascular and interventional radiology : JVIR.

[8]  R. Chaer,et al.  Catheter interventions: an unresolved clinical controversy. , 2020, The Lancet. Haematology.

[9]  W. Jordan,et al.  Technical success and short-term outcomes after treatment of lower extremity deep vein thrombosis with the ClotTriever system: A preliminary experience. , 2019, Journal of vascular surgery. Venous and lymphatic disorders.

[10]  L. Tick,et al.  Ultrasound-accelerated catheter-directed thrombolysis versus anticoagulation for the prevention of post-thrombotic syndrome (CAVA): a single-blind, multicentre, randomised trial. , 2019, The Lancet. Haematology.

[11]  S. Goldhaber,et al.  Cost-Effectiveness of Pharmacomechanical Catheter-Directed Thrombolysis Versus Standard Anticoagulation in Patients With Proximal Deep Vein Thrombosis: Results From the ATTRACT Trial. , 2019, Circulation. Cardiovascular quality and outcomes.

[12]  S. Goldhaber,et al.  Relationships between the use of pharmacomechanical catheter-directed thrombolysis, sonographic findings, and clinical outcomes in patients with acute proximal DVT: Results from the ATTRACT Multicenter Randomized Trial , 2019, Vascular medicine.

[13]  H. Bjarnason,et al.  Aspiration thrombectomy for acute iliofemoral or central deep venous thrombosis. , 2019, Journal of vascular surgery. Venous and lymphatic disorders.

[14]  L. Hofmann,et al.  Endovascular Thrombus Removal for Acute Iliofemoral Deep Vein Thrombosis: Analysis From a Stratified Multicenter Randomized Trial , 2019, Circulation.

[15]  S. Goldhaber,et al.  Pharmacomechanical Catheter-Directed Thrombolysis in Acute Femoral–Popliteal Deep Vein Thrombosis: Analysis from a Stratified Randomized Trial , 2019, Thrombosis and Haemostasis.

[16]  P. Wells,et al.  Venous Thromboembolism: Advances in Diagnosis and Treatment , 2018, JAMA.

[17]  G. O'Sullivan,et al.  Just How Attractive is the ATTRACT Trial? , 2018, CardioVascular and Interventional Radiology.

[18]  Chaonan Wang,et al.  Percutaneous Endovenous Intervention Plus Anticoagulation versus Anticoagulation Alone for Treating Patients with Proximal Deep Vein Thrombosis: A Meta-analysis and Systematic Review. , 2018, Annals of vascular surgery.

[19]  R. Chaer,et al.  The ATTRACTiveness of catheter-directed thrombolysis. , 2018, Journal of vascular surgery. Venous and lymphatic disorders.

[20]  S. Goldhaber,et al.  Pharmacomechanical Catheter‐Directed Thrombolysis for Deep‐Vein Thrombosis , 2017, The New England journal of medicine.

[21]  W. Jo,et al.  The Role of Pharmacomechanical Endovascular Intervention for Iliofemoral Vein Thrombosis Compared to Conventional Anticoagulation Therapy , 2016, Journal of Korean medical science.

[22]  L. Sandvik,et al.  Post-thrombotic syndrome after catheter-directed thrombolysis for deep vein thrombosis (CaVenT): 5-year follow-up results of an open-label, randomised controlled trial. , 2016, The Lancet. Haematology.

[23]  S. Kahn,et al.  Guidance for the prevention and treatment of the post-thrombotic syndrome , 2016, Journal of Thrombosis and Thrombolysis.

[24]  Jichun Zhao,et al.  Catheter-directed thrombolysis plus anticoagulation versus anticoagulation alone in the treatment of proximal deep vein thrombosis - a meta-analysis. , 2015, VASA. Zeitschrift fur Gefasskrankheiten.

[25]  C. Wittens,et al.  Thrombectomy without lysis: the future? , 2014, Phlebology.

[26]  L. Sandvik,et al.  Residual rates of reflux and obstruction and their correlation to post-thrombotic syndrome in a randomized study on catheter-directed thrombolysis for deep vein thrombosis. , 2014, Journal of vascular surgery. Venous and lymphatic disorders.

[27]  P. Sandset,et al.  Symptom burden and job absenteeism after treatment with additional catheter-directed thrombolysis for deep vein thrombosis , 2013, Patient related outcome measures.

[28]  Elie A Akl,et al.  Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. , 2012, Chest.

[29]  L. Sandvik,et al.  Long-term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): a randomised controlled trial , 2012, The Lancet.

[30]  B. Geier,et al.  Long-term results after transfemoral venous thrombectomy for iliofemoral deep venous thrombosis. , 2010, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[31]  A. Gasparis,et al.  Recurrent Deep Vein Thrombosis: Long-Term Incidence and Natural History , 2010, Annals of surgery.

[32]  L. Sandvik,et al.  Catheter‐directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting on short‐term patency , 2009, Journal of thrombosis and haemostasis : JTH.

[33]  O. Hartung,et al.  Late results of surgical venous thrombectomy with iliocaval stenting. , 2008, Journal of vascular surgery.

[34]  M. Elsharawy,et al.  Early results of thrombolysis vs anticoagulation in iliofemoral venous thrombosis. A randomised clinical trial. , 2002, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[35]  Attract Trial Investigators.  Quality of life after pharmacomechanical catheter-directed thrombolysis for proximal deep venous thrombosis. , 2020 .

[36]  W. Marston.  Results of the ATTRACT trial do not change the management of acute deep vein thrombosis. , 2018, Journal of vascular surgery. Venous and lymphatic disorders.